<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">N</forename><surname>Fitch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Irene</forename><surname>Margiolaki</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Genetics, Cell Biology and Development</orgName>
								<orgName type="department" key="dep2">Department of Biology</orgName>
								<orgName type="institution" key="instit1">University of Patras</orgName>
								<orgName type="institution" key="instit2">University of Patras Campus</orgName>
								<address>
									<postCode>GR-26500</postCode>
									<settlement>Patras</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Spiliopoulou</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Genetics, Cell Biology and Development</orgName>
								<orgName type="department" key="dep2">Department of Biology</orgName>
								<orgName type="institution" key="instit1">University of Patras</orgName>
								<orgName type="institution" key="instit2">University of Patras Campus</orgName>
								<address>
									<postCode>GR-26500</postCode>
									<settlement>Patras</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dimitris</forename><forename type="middle">P</forename><surname>Triandafillidis</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Hamburg Centre for Ultrafast Imaging</orgName>
								<orgName type="institution">Universität Hamburg</orgName>
								<address>
									<addrLine>HARBOR (Building 610) Luruper Chaussee 149</addrLine>
									<postCode>DE-22761</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Athanasiadou</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Section of Genetics, Cell Biology and Development</orgName>
								<orgName type="department" key="dep2">Department of Biology</orgName>
								<orgName type="institution" key="instit1">University of Patras</orgName>
								<orgName type="institution" key="instit2">University of Patras Campus</orgName>
								<address>
									<postCode>GR-26500</postCode>
									<settlement>Patras</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">EUROPEAN SYNCHROTRON RADIATION FACILITY</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">6E007BF8D0764BB5D1C492F965AC36BE</idno>
					<note type="submission">from: 30 November 2021 to: 4 December 2021</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T15:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>LS-3012</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report</head><p>In the present experiment we collected X-Ray Powder Diffraction (XRPD) data from macromolecular samples on ID22, the high-resolution powder diffraction beamline at ESRF. Approximately 200 samples of human insulin cocrystallized with various small organic ligands at different pH levels were measured during this experiment. Human insulin is a highly polymorphic protein, with 3 distinct molecular conformations and crystallizing in over 30 crystal forms (i.e. crystal polymorphs) by variation of its physicochemical environment. Our team has been systematically exploring the phase map of human insulin upon ligand binding and pH variation, for the development of novel, more effective, crystalline, anti-diabetic formulations (Figure <ref type="figure" target="#fig_0">1</ref>; <ref type="bibr" target="#b2">Spiliopoulou et al., 2020)</ref>.</p><p>Using an already established crystallization protocol, we prepared insulin samples with 11 different ligands, namely derivatives of phenol (phenol, 4-nitrophenol, p-coumaric acid, resveratrol), resorcinol (resorcinol, α-resorcylic acid, βresorcylic acid) and benzoic acid (benzoic acid, 4hydroxybenzoic acid, gentisic acid, gallic acid). Data were collected from borosilicate glass capillaries loaded with the polycrystalline slurries, employing the new 13-channel crystal analyzer stage and the EIGER 2M detector. The data were then indexed, and Pawley refinements were performed, enabling the extraction of accurate unit-cell parameters for each phase present per samples. Multiphase refinements were performed for datasets with co-existing crystal polymorphs.</p><p>Contrary to single-crystal techniques, the ability to characterize the entire crystalline sample with powder diffraction has proven to be crucial in our case. While the high polymorphicity of human insulin constitutes it an ideal target for polymorph screening experiments, at the same time, slight variations on the crystallization protocols can lead to vastly different polymorphs. For the past two years we have been trying to grow single crystals for several polymorphs of interest, especially for phenol and resorcinol complexes. By adapting the batch protocols for single crystal growth, we have introduced additional variation to the crystallization condition, resulting in our inability to grow crystals of certain polymorphs. By collecting data at ID22 from samples grown with multiple crystallization protocols, we were finally able to identify the factors affecting polymorph selection on our samples. Using the insights from the high-resolution XRPD data, we managed to grow single crystals for the polymorphs of interest and collect diffraction data at other synchrotron facilities. Structure solution and refinement is still ongoing.</p><p>During our experiment, we also collected a few datasets which were then reprocessed to reduce the axial divergence, that is especially pronounced at the low 2θ range, by employing the 2D segments recorded by the EIGER detector <ref type="bibr" target="#b0">(Fitch and Dejoie, 2021)</ref>. We chose to collect data from certain polymorphs with unit-cell volumes ranging from 1,000,000 to 3,000,000 Å 3 , which have several peaks at the low angle region. The resulting reprocessed data exhibited a remarkable improvement in peak asymmetry, further reducing the heavy peak overlap observed in macromolecular XRPD (Figure <ref type="figure" target="#fig_1">2</ref>). These data have enabled us to attempt Rietveld refinement on these polymorphs, for the first after 10 years, when we first identified them at ID22 <ref type="bibr" target="#b1">(Karavassili et al., 2012)</ref>.</p><p>Overall, the data collected at ID22 have enriched the ever-expanding phase map of human insulin, guided subsequent singlecrystal experiments and enabled structure refinement attempts of polymorphs that were previously considered too hard to tackle via powder diffraction. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1:The ever-expanding phase map of human insulin co-crystallized with various ligands and at varying pH levels, as determined by our team using ID22 data over the years. Different colors correspond to distinct crystal polymorphs.</figDesc><graphic coords="2,342.03,67.68,225.44,244.89" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc>Figure 2: Multiphase Pawley refinement of polycrystalline human insulin sample co-crystallized with phenol. Data collected at ID22 with the 13channel crystal analyzer stage, with (bottom) and without (top) axial divergence reprocessing. An additional polymorph (green ticks) could be identified from the reprocessed data. Vertical ticks correspond to Bragg peaks of the different polymorphs: C222 1 (orange), C2 (magenta), R3 T3R3 (blue), R3 T3R3' (green).</figDesc><graphic coords="3,254.95,84.35,314.48,293.15" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Combining a multi-analyzer stage with a two-dimensional detector for high-resolution powder X-ray diffraction: correcting the angular scale</title>
		<author>
			<persName><forename type="first">Andrew</forename><surname>Fitch</surname></persName>
			<idno type="ORCID">0000-0002-9768-5688</idno>
		</author>
		<author>
			<persName><forename type="first">Catherine</forename><surname>Dejoie</surname></persName>
			<idno type="ORCID">0000-0003-3313-3515</idno>
		</author>
		<idno type="DOI">10.1107/s1600576721005288</idno>
		<ptr target="https://doi.org/10.1107/S1600576721005288" />
	</analytic>
	<monogr>
		<title level="j">Journal of Applied Crystallography</title>
		<title level="j" type="abbrev">J Appl Crystallogr</title>
		<idno type="ISSNe">1600-5767</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1088" to="1099" />
			<date type="published" when="2021-07-07">2021</date>
			<publisher>International Union of Crystallography (IUCr)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Fitch, A., Dejoie, C., 2021. Combining a multi-analyzer stage with a two-dimensional detector for high- resolution powder X-ray diffraction: correcting the angular scale. J Appl Crystallogr 54, 1088-1099. https://doi.org/10.1107/S1600576721005288</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Structural studies of human insulin cocrystallized with phenol or resorcinol&lt;i&gt;via&lt;/i&gt;powder diffraction</title>
		<author>
			<persName><forename type="first">Fotini</forename><surname>Karavassili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anastasia</forename><forename type="middle">E</forename><surname>Giannopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eleni</forename><surname>Kotsiliti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lisa</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mathias</forename><surname>Norrman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gerd</forename><surname>Schluckebier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lene</forename><surname>Drube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrew</forename><forename type="middle">N</forename><surname>Fitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jonathan</forename><forename type="middle">P</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Irene</forename><surname>Margiolaki</surname></persName>
		</author>
		<idno type="DOI">10.1107/s0907444912039339</idno>
		<ptr target="https://doi.org/10.1107/S0907444912039339" />
	</analytic>
	<monogr>
		<title level="j">Acta Crystallographica Section D Biological Crystallography</title>
		<title level="j" type="abbrev">Acta Crystallogr D Biol Crystallogr</title>
		<idno type="ISSN">0907-4449</idno>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1632" to="1641" />
			<date type="published" when="2012-11-09">2012</date>
			<publisher>International Union of Crystallography (IUCr)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Karavassili, F., Giannopoulou, A.E., Kotsiliti, E., Knight, L., Norrman, M., Schluckebier, G., Drube, L., Fitch, A.N., Wright, J.P., Margiolaki, I., 2012. Structural studies of human insulin cocrystallized with phenol or resorcinol via powder diffraction. Acta Crystallographica Section D Biological Crystallography 68, 1632-1641. https://doi.org/10.1107/S0907444912039339</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Applications of X-ray Powder Diffraction in Protein Crystallography and Drug Screening</title>
		<author>
			<persName><forename type="first">Maria</forename><surname>Spiliopoulou</surname></persName>
			<idno type="ORCID">0000-0002-4537-9769</idno>
		</author>
		<author>
			<persName><forename type="first">Alexandros</forename><surname>Valmas</surname></persName>
			<idno type="ORCID">0000-0003-1696-0551</idno>
		</author>
		<author>
			<persName><forename type="first">Dimitris-Panagiotis</forename><surname>Triandafillidis</surname></persName>
			<idno type="ORCID">0000-0003-4242-7785</idno>
		</author>
		<author>
			<persName><forename type="first">Christos</forename><surname>Kosinas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrew</forename><surname>Fitch</surname></persName>
			<idno type="ORCID">0000-0002-9768-5688</idno>
		</author>
		<author>
			<persName><forename type="first">Fotini</forename><surname>Karavassili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Irene</forename><surname>Margiolaki</surname></persName>
		</author>
		<idno type="DOI">10.3390/cryst10020054</idno>
		<ptr target="https://doi.org/10.3390/cryst10020054" />
	</analytic>
	<monogr>
		<title level="j">Crystals</title>
		<title level="j" type="abbrev">Crystals</title>
		<idno type="ISSNe">2073-4352</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2020-01-21">2020</date>
			<publisher>MDPI AG</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Spiliopoulou, M., Valmas, A., Triandafillidis, D.-P., Kosinas, C., Fitch, A., Karavassili, F., Margiolaki, I., 2020. Applications of X-ray Powder Diffraction in Protein Crystallography and Drug Screening. Crystals 10, 54. https://doi.org/10.3390/cryst10020054</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
